跳至主要内容
临床试验/NCT03221998
NCT03221998Unknown早期 1 期

The Effect of Timing of Intravenous Paracetamol Administration on Post-surgical Pain and Cytokines Levels Following Laparoscopic Sleeve Gastrectomy

Soroka University Medical Center0 个研究点目标入组 126 人开始时间: 2017年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
入组人数
126
主要终点
measuring of Visual Analogue pain Scale,

研究概览

简要总结

This study is designed as a population-based prospective randomized cohort study. A prospective cohort of patients admitted to laparoscopic sleeve gastrectomy due to morbid obesity

详细描述

All adult consecutive patients admitted to surgical departments for laparoscopic sleeve gastrectomy will be enrolled prospectively.

For the purposes of the current study we want to determine how much paracetamol (acetaminophen) can reduce the cytokines levels in these patients

The study enrollment period is planned to be a year. The follow-up period for each patient will be until discharge from the hospital.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥18 years
  • Patients admitted for laparoscopic sleeve gastrectomy
  • Elective surgery
  • BMI > 40
  • American Society of Anesthesiology Classification: 1-2

排除标准

  • Patients' refusal to participate in the study
  • Patients unable to give an informed consent
  • Pregnancy
  • Emergency surgery
  • Patient with known allergy to paracetamol
  • Patient with hepatic failure
  • international normalized ratio >1.7
  • Albumin<3.5g/Dl
  • Bilirubin >2mg/dL
  • Patient with fever > 37.5 ° C
  • Patient with hemoglobin < 8
  • Patients chronically treated with steroids or steroid-treated patients over a month in the year preceding surgery.
  • Drug addict

研究组 & 干预措施

IV paracetamol

Experimental

Patients in the first group will receive in the operating room before surgery 1 gram (100 ml) of intravenous paracetamol ( IV paracetamol) for 15 minutes intraoperative

干预措施: IV paracetamol (Drug)

IV saline (NaCl 0.9 %)

Placebo Comparator

Patients in the second group will receive 100 mL NACL 0.9% (IV NaCl 0.9 %)intraoperative

干预措施: IV saline (NaCl 0.9 %) (Drug)

结局指标

主要结局

measuring of Visual Analogue pain Scale,

时间窗: up to 48 hours after surgery

Visual Analogue pain Scale to determine patient level of pain , for establish the correct timing of paracetamol administration

measuring of Cytokine levels

时间窗: up to 48 hours after surgery

measuring of Cytokine levels in comparison of timing of paracetamol administration , as a predictor for inflammatory mediators released in response to noxious stimuli

次要结局

  • septic post-operative complication while recovering in post anesthesia care unit(up to 5 hours after surgery)
  • urinary trak post-operative complication while in ward(up to 72 hours after surgery)
  • post-operative pruritus while in ward(up to 72 hours after surgery)
  • post-operative hospitalization(up to one week after surgery)
  • Total consumption of opiates after surgery(up to 72 hours after surgery)
  • Gastrointestinal post-operative complication while recovering in post anesthesia care unit(up to 5 hours after surgery)
  • Respiratory post-operative complication while in ward(up to 72 hours after surgery)
  • septic post-operative complication while in ward(up to 72 hours after surgery)
  • Cardiovascular post-operative complication while in ward(up to 72 hours after surgery)
  • Gastrointestinal post-operative complication while in ward(up to 72 hours after surgery)
  • Respiratory post-operative complication while recovering in post anesthesia care unit(up to 5 hours after surgery)
  • Cardiovascular post-operative complication while recovering in post anesthesia care unit(up to 5 hours after surgery)
  • post-operative stay in post anesthesia care unit(up to 5 hours after surgery)
  • urinary retention post-operative complication while recovering in post anesthesia care unit(up to 5 hours after surgery)
  • post-operative pruritus while recovering in post anesthesia care unit(up to 5 hours after surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yair Binyamin MD

principal lnvestigator

Soroka University Medical Center

相似试验